Copyright
©The Author(s) 2024.
World J Psychiatry. Jan 19, 2025; 15(1): 98630
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98630
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98630
Data | Cases | SDS score (mean ± SD) | Z/t | P value |
Sex | -0.537 | 0.591 | ||
Male | 56 | 11.27 ± 3.37 | ||
Female | 102 | 11.53 ± 3.33 | ||
Degree of depression | 0.575 | 0.750 | ||
Mild | 45 | 11.42 ± 3.86 | ||
Moderate | 110 | 11.54 ± 3.07 | ||
Severe | 3 | 13.00 ± 2.16 | ||
Disease history | -4.432 | < 0.001 | ||
First-episode | 67 | 10.03 ± 3.08 | ||
Recurrence | 91 | 12.49 ± 2.88 | ||
Family history of depression | 0.6901 | 0.491 | ||
Yes | 33 | 11.15 ± 2.78 | ||
No | 125 | 11.61 ± 3.39 | ||
Family history of depression | -0.719 | 0.472 | ||
1 | 13 | 12.08 ± 2.53 | ||
≥ 2 | 145 | 11.49 ± 3.37 | ||
Use of antipsychotics | -1.3891 | 0.167 | ||
Yes | 31 | 12.23 ± 2.85 | ||
No | 127 | 11.23 ± 3.26 | ||
Use of sedative and hypnotic drugs | -1.121 | 0.262 | ||
Yes | 6 | 13.00 ± 2.45 | ||
No | 152 | 11.54 ± 3.20 | ||
Medication compliance | -5.191 | < 0.001 | ||
Stick to medication | 140 | 10.77 ± 2.81 | ||
Intermittent medication use | 18 | 15.50 ± 2.36 | ||
Therapy method | -7.546 | < 0.001 | ||
Drug therapy alone | 56 | 14.02 ± 2.66 | ||
Drugs and nursing intervention | 102 | 9.79 ± 2.60 | ||
Comorbidities | -0.6371 | 0.525 | ||
Yes | 19 | 11.95 ± 3.35 | ||
No | 139 | 11.50 ± 3.38 | ||
Degree of somatic symptoms | 48.032 | < 0.001 | ||
None | 48 | 9.35 ± 2.71 | ||
Mild | 36 | 11.97 ± 3.39 | ||
Moderate | 49 | 12.08 ± 2.83 | ||
Severe | 25 | 13.80 ± 2.24 | ||
Residual symptoms | -5.710 | < 0.001 | ||
Slight | 107 | 10.46 ± 3.37 | ||
Obvious | 51 | 13.51 ± 2.46 | ||
Age | -0.584 | 0.559 | ||
< 40 years | 70 | 11.56 ± 3.24 | ||
≥ 40 years | 88 | 11.36 ± 3.38 | ||
Years of education | -0.072 | 0.943 | ||
< 12 years | 80 | 11.36 ± 3.25 | ||
≥ 12 years | 78 | 11.56 ± 3.37 | ||
Duration from illness onset to hospital visit | -0.300 | 0.943 | ||
< 3 years | 26 | 11.62 ± 3.05 | ||
≥ 3 years | 132 | 11.39 ± 3.31 | ||
Duration of depressive episode | -1.149 | 0.251 | ||
< 16 weeks | 80 | 10.83 ± 3.00 | ||
≥ 16 weeks | 78 | 11.91 ± 3.41 | ||
SSRS score | -0.219 | 0.827 | ||
< 28 | 68 | 11.60 ± 3.59 | ||
≥ 28 | 90 | 11.20 ± 3.00 | ||
LES score | -1.429 | 0.153 | ||
< 42 | 78 | 11.80 ± 3.21 | ||
≥ 42 | 80 | 11.14 ± 3.34 | ||
FAD score | -1.735 | 0.083 | ||
< 138 | 78 | 10.97 ± 3.35 | ||
≥ 138 | 80 | 11.94 ± 3.20 | ||
Anxiety score | -2.353 | 0.019 | ||
< 8 | 74 | 10.86 ± 2.77 | ||
≥ 8 | 84 | 11.86 ± 3.57 | ||
Stigma at discharge score | -1.0181 | 0.310 | ||
< 75 | 65 | 11.18 ± 3.19 | ||
≥ 75 | 93 | 11.51 ± 3.90 |
- Citation: Liao ZL, Pu XL, Zheng ZY, Luo J. Social function scores and influencing factors in patients with residual depressive symptoms. World J Psychiatry 2025; 15(1): 98630
- URL: https://www.wjgnet.com/2220-3206/full/v15/i1/98630.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i1.98630